Bloomage Biotechnology Corp Ltd (688363) - Total Liabilities
Based on the latest financial reports, Bloomage Biotechnology Corp Ltd (688363) has total liabilities worth CN¥1.59 Billion CNY (≈ $232.72 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 688363 net asset momentum to track the company's year-over-year net asset growth rate.
Bloomage Biotechnology Corp Ltd - Total Liabilities Trend (2012–2025)
This chart illustrates how Bloomage Biotechnology Corp Ltd's total liabilities have evolved over time, based on quarterly financial data. See cash generation quality of Bloomage Biotechnology Corp Ltd to measure how efficiently the company converts operating cash flow to free cash.
Bloomage Biotechnology Corp Ltd Competitors by Total Liabilities
The table below lists competitors of Bloomage Biotechnology Corp Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Fibra Danhos
MX:DANHOS13
|
Mexico | MX$13.89 Billion |
|
Air China Limited
F:AD2
|
Germany | €303.82 Billion |
|
Ligand Pharmaceuticals Incorporated
NASDAQ:LGND
|
USA | $534.78 Million |
|
Cargotec Oyj
HE:CGCBV
|
Finland | €1.46 Billion |
|
West African Resources Ltd
AU:WAF
|
Australia | AU$806.24 Million |
|
Multiplan Empreendimentos Imobiliários S.A
SA:MULT3
|
Brazil | R$6.82 Billion |
|
Hangzhou Cable
SHG:603618
|
China | CN¥8.06 Billion |
|
Huaming Power Equipment Co Ltd
SHE:002270
|
China | CN¥1.35 Billion |
Liability Composition Analysis (2012–2025)
This chart breaks down Bloomage Biotechnology Corp Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Bloomage Biotechnology Corp Ltd (688363) total market value.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.36 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.22 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.18 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Bloomage Biotechnology Corp Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Bloomage Biotechnology Corp Ltd (2012–2025)
The table below shows the annual total liabilities of Bloomage Biotechnology Corp Ltd from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥1.58 Billion ≈ $230.82 Million |
-13.19% |
| 2024-12-31 | CN¥1.82 Billion ≈ $265.87 Million |
+22.22% |
| 2023-12-31 | CN¥1.49 Billion ≈ $217.53 Million |
-25.63% |
| 2022-12-31 | CN¥2.00 Billion ≈ $292.48 Million |
+10.96% |
| 2021-12-31 | CN¥1.80 Billion ≈ $263.58 Million |
+189.28% |
| 2020-12-31 | CN¥622.68 Million ≈ $91.12 Million |
+47.52% |
| 2019-12-31 | CN¥422.11 Million ≈ $61.77 Million |
+19.39% |
| 2018-12-31 | CN¥353.56 Million ≈ $51.74 Million |
+44.10% |
| 2017-12-31 | CN¥245.35 Million ≈ $35.90 Million |
-42.07% |
| 2016-12-31 | CN¥423.53 Million ≈ $61.98 Million |
-57.95% |
| 2015-12-31 | CN¥1.01 Billion ≈ $147.39 Million |
+373.01% |
| 2014-12-31 | CN¥212.94 Million ≈ $31.16 Million |
+4.40% |
| 2013-12-31 | CN¥203.96 Million ≈ $29.85 Million |
+109.65% |
| 2012-12-31 | CN¥97.29 Million ≈ $14.24 Million |
-- |
About Bloomage Biotechnology Corp Ltd
Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers pharmaceutical grade sodium hyaluronate which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature nam… Read more